CD274 and non-small cell lung carcinoma: On the contrary, one group recently showed that AC was not associated with better progression free survival (PFS) or overall survival (OS) in non-small cell lung cancer (NSCLC) patients treated with PD-1 or PD-L1 blockade [9].